Business UpdateMay 19, 2026, 06:08 AM
Innate Pharma to Attend Jefferies Global Healthcare Conference
AI Summary
Innate Pharma SA announced its participation in the Jefferies Global Healthcare Conference 2026, scheduled from June 2–4, 2026, in New York, United States. The company will hold one-on-one investor meetings during the event. Innate Pharma is a clinical-stage biotechnology company focused on developing immunotherapies for cancer patients, leveraging its expertise in antibody-engineering and innovative target identification.
Key Highlights
- Innate Pharma will attend the Jefferies Global Healthcare Conference 2026.
- The conference is scheduled for June 2–4, 2026, in New York, United States.
- The company will participate in one-on-one investor meetings.
- Innate Pharma is a clinical-stage biotechnology company developing immunotherapies for cancer.
- Its pipeline includes IPH4502, lacutamab, and monalizumab.
- The company has collaborations with Sanofi and AstraZeneca.
Price Impact
More from IPHA